Diversity Analysis of Vaginal Microbiota on Women With High-risk Human Papillomavirus Infection

NCT03548740 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 151

Last updated 2019-02-06

No results posted yet for this study

Summary

Since other genital infections enhance HIV susceptibility by inducing inflammation, the investigators study the relationship between the vaginal microbiota composition and the risk of HPV infection, cervical cytological abnormalities.

Conditions

  • Papillomavirus Infections

Interventions

BIOLOGICAL

Human Papillomavirus

women with high-risk Human Papillomavirus or not

Sponsors & Collaborators

  • Peking Union Medical College Hospital

    lead OTHER

Eligibility

Min Age
25 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-09-01
Primary Completion
2020-01-20
Completion
2020-05-20

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03548740 on ClinicalTrials.gov